You are here:
Faecal microbiota transplantation (FMT, stool transplantation): Risk of transmission of multi-resistant bacteria
2019.06.18
Active substance: FMT
The American Food and Drug Administration (FDA) warns of the risk of serious bacterial infections caused by the transmission of multi-resistant bacteria during faecal microbiota transplants (FMT).
To the risk information full text (available in German only)